<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03007589</url>
  </required_header>
  <id_info>
    <org_study_id>SPF-2014-001</org_study_id>
    <nct_id>NCT03007589</nct_id>
  </id_info>
  <brief_title>Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics</brief_title>
  <official_title>Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Protection Foundation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Protection Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess how sunscreens and sun protection fabrics perform in&#xD;
      natural sunlight compared to their labeled claims, indoor testing methods (existing or&#xD;
      modified) and instructions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the difference in the level of erythema and persistent pigment darkening sun&#xD;
      protection following a single period of natural sunlight exposure or laboratory solar&#xD;
      simulator exposure afforded by application of sunscreens, use of fabrics, and use of pass&#xD;
      through glass filters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Anticipated">January 2030</completion_date>
  <primary_completion_date type="Anticipated">January 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Erythema</measure>
    <time_frame>16-24 hours post exposure to natural sunlight</time_frame>
    <description>â€¢ Erythema was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible erythema but spotty or without clear borders (&lt;1 MED); 2 = minimal erythema over the entire site with distinct borders (1 MED reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters.&#xD;
Determination made by blinded evaluator on-site or using chroma-meter and photographs.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Persistent Pigment Darkening (PPD)</measure>
    <time_frame>16-24 hours post exposure to natural sunlight</time_frame>
    <description>Persistent Pigment Darkening was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible but spotty or without clear borders (&lt;1 MPPDD); 2 = minimal PPD over the entire site with distinct borders (1 MPPDD reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters&#xD;
Determination made by blinded evaluator on-site or using chroma-meter and photographs.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sunburn</condition>
  <condition>Sun Damaged Skin</condition>
  <condition>Overexposure to Sun Rays</condition>
  <arm_group>
    <arm_group_label>Location</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Location and Intensity of Exposure to Sunlight otc sunscreens sun protection fabrics optical filters</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single Duration or SPF Test</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single exposure of interventions or multiple exposures of interventions (SPF or PPD-PF tests) otc sunscreens sun protection fabrics optical filters</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>otc sunscreens</intervention_name>
    <description>Sunscreens of various SPF levels and ingredients</description>
    <arm_group_label>Location</arm_group_label>
    <arm_group_label>Single Duration or SPF Test</arm_group_label>
    <other_name>30 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>40 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>45 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>50 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>60 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>100 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>110 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>Sunscreen Standard P2 15 SPF</other_name>
    <other_name>Sunscreen Standard S2 12 UVA-PF</other_name>
    <other_name>Sunscreen Standard P1 4 SPF</other_name>
    <other_name>70 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>85 SPF Broad Spectrum Sunscreen</other_name>
    <other_name>16 SPF Reference Standard Sunscreen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sun protection fabrics</intervention_name>
    <description>fabrics</description>
    <arm_group_label>Location</arm_group_label>
    <arm_group_label>Single Duration or SPF Test</arm_group_label>
    <other_name>100+ SPF Broad Spectrum Fabric Solumbra</other_name>
    <other_name>30+ SPF Broad Spectrum Fabric Solumbra</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optical Filters</intervention_name>
    <description>Optical filters and surfaces used in solar simulators</description>
    <arm_group_label>Location</arm_group_label>
    <arm_group_label>Single Duration or SPF Test</arm_group_label>
    <other_name>Pass Through Glass</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Fitzpatrick Type I, II, III, IV or V type skin.&#xD;
&#xD;
          2. Must be able to be exposed to natural sunlight for up to 4 hours in a prone position&#xD;
&#xD;
          3. Able to read, write, speak and understand the English language.&#xD;
&#xD;
          4. Has personally read, signed, and dated the Informed Consent Form (including HIPAA&#xD;
             disclosure) and Photograph Release&#xD;
&#xD;
          5. Generally in good health based on medical history reported by the subject&#xD;
&#xD;
          6. Healthy male or female subjects with no history or evidence of clinically relevant&#xD;
             medical disorder, as determined from a brief medical history interview.&#xD;
&#xD;
          7. Willing and able to follow the study instructions, including:&#xD;
&#xD;
               -  Remain outdoors exposed to the sun or in the laboratory for up to 4 hours on Day&#xD;
                  1 during the study with exposed skin on back protected by sunscreens and fabrics&#xD;
&#xD;
               -  Apply the specific sunscreens and fabrics to designated sites on the back and lie&#xD;
                  motionless.&#xD;
&#xD;
               -  No visual signs of recent sun exposure to the back.&#xD;
&#xD;
               -  No sunscreens or lotions recently used on the back.&#xD;
&#xD;
               -  Attend scheduled visits and intend to successfully complete the study&#xD;
&#xD;
               -  Stay out of the sun or stay indoors from sun exposure until after observation on&#xD;
                  Day 2.&#xD;
&#xD;
               -  Women are discouraged from using a bra that applies pressure to the skin site&#xD;
                  areas that may make it difficult to assess erythema or PPD on Day 2.&#xD;
&#xD;
               -  Refrain from using other sunscreen products or tanning bed use during the&#xD;
                  duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Individuals with known allergies or sensitivities to sunscreens or any ingredient&#xD;
             contained in the test products or common topical skincare products, including&#xD;
             adhesives.&#xD;
&#xD;
          2. Perceptible erythema, PPD on the back as determined by the PI or designee.&#xD;
&#xD;
          3. Women known to be pregnant or nursing.&#xD;
&#xD;
          4. Individuals with any disease or condition of the skin (e.g., active [i.e. flaring]&#xD;
             eczema or psoriasis, skin cancer, atypical nevus, polymorphic light eruption (PMLE),&#xD;
             porphyria, systemic lupus erythematous (SLE), xeroderma pigmentosa (XP)) that could&#xD;
             interfere with the study or increase risk to the subject.&#xD;
&#xD;
          5. Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes,&#xD;
             hypertension, hyper/hypothyroidism, hypercholesterolemia&#xD;
&#xD;
          6. Subjects who are taking medication for chronic conditions that may make a subject more&#xD;
             sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.)&#xD;
&#xD;
          7. Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may&#xD;
             influence the outcome of the study&#xD;
&#xD;
          8. An individual who has any condition which in the PI's judgment makes the candidate an&#xD;
             inappropriate subject for study participation&#xD;
&#xD;
          9. Individuals with a condition or situation which, in the PI's opinion, may put the&#xD;
             subject at significant risk, may confound the study results, or may interfere&#xD;
             significantly with the subject's participation in the study&#xD;
&#xD;
         10. Individual viewed by the PI as not being able to complete the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaun Hughes, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Protection Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sun Protection Foundation</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Protection Foundation</name>
      <address>
        <city>Waimea</city>
        <state>Hawaii</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Protection Foundation</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Protection Foundation</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Protection Foundation</name>
      <address>
        <city>Arequipa</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>Peru</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>December 26, 2016</study_first_submitted>
  <study_first_submitted_qc>December 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2017</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>erythema</keyword>
  <keyword>persistent pigment darkening</keyword>
  <keyword>sunburn</keyword>
  <keyword>suntan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sunburn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sunscreening Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

